| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Health Care (XLV) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The overall sentiment for Health Care sector is very bullish (overall 2.5, positive 2.7, negative -0.3) on 20251202. The forces of Sentiment towards Fundamentals (2.1), Option Sentiment (1.5), Valuation Sentiment (0.9), Market Risk Appetite (0.5), Broad Market Trend (0.4), and Price Level Sentiment (0) will drive up the price. The forces of and Sector Price Trend (-0.5) will drive down the price. 'Long' is the preferred trading strategy. The swing to upside will be significant considering the high positive sentiment forces (2.7). The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XLV trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Action | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-02 | 1% | 1% | 154.32 | 64 | -0.64% | 0.19% | 2.5 | -0.5 | Range | 2.1 | 5 |
| 2025-12-01 | 2% | 1% | 155.32 | 72 | -1.43% | 0.19% | 2.5 | 0.3 | Range | 2 | -0.1 |
| 2025-11-30 | 0% | 1.1% | 3.6 | 1 | Long | 1.9 | 1 | ||||
| 2025-11-29 | 1% | 1.3% | 3.4 | 1 | Long | 2 | 6 | ||||
| 2025-11-28 | 0% | 1.3% | 157.58 | 86 | -0.5% | 0.32% | 4.2 | 1 | Long | 2 | 1.5 |
| 2025-11-27 | 0% | 1.7% | 3.8 | 1 | Long | 2.3 | -1 | ||||
| 2025-11-26 | 3% | 2% | 158.37 | 95 | -0.25% | 0.39% | 3.9 | 1 | Range | 2.6 | 3 |
| 2025-11-25 | 1% | 1.7% | 158.76 | 103 | 2.26% | 0.52% | 4 | 1.8 | Range | 2.9 | 5.1 |
| 2025-11-24 | 3% | 1.9% | 155.25 | 91 | 0.38% | 0.53% | 4.5 | 1.3 | Range | 3.2 | -0.8 |
| 2025-11-23 | 1% | 1.7% | 4.4 | 1 | Long | 2.7 | -8 | ||||
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. | Range refers to range trade strategy. In an uptrend, the price will likely bullback after huge advance. As an investor, you may want to wait for the pullback to open long position. As a trader, you may consider tactical short. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. As a trader, you may consider tactical long. |
| 1 (8) Jim Cramer has faith in Danaher's turnaround as life sciences comes back to life Life sciences stocks are seeing a resurgence — and that's good news for Danaher. (https://www.cnbc.com/) Tue. Dec 2, 2025 | |
| 2 (8) Health Insurer Curative Valued at $1.28 Billion in Fund Raise Curative, a startup health insurance company that aims to reduce costs by encouraging people to get preventative care, has raised more than $150 million in a bid to redesign how employer health benefits work. (https://www.bloomberg.com/) Tue. Dec 2, 2025 | |
| 3 (5) Bayer shares pop 12% after Trump administration backs curbing of Roundup lawsuits; European stocks edge higher European stocks moved higher on Tuesday, with shares struggling to find momentum after a broad sell-off marked the first day of the new month. (https://www.cnbc.com/) Tue. Dec 2, 2025 | |
| 4 (8) Bank of America hikes Eli Lilly price target on promising drug pipeline Bank of America's new price target has shares of Eli Lilly climbing 22% from here. (https://www.cnbc.com/) Tue. Dec 2, 2025 | |
| 5 (8) 2 Top Dividend Stocks to Buy Now and Hold For a Decade These healthcare leaders can make you money while you sleep. (https://www.fool.com/) Tue. Dec 2, 2025 | |
| 6 (8) Bayer stock has its best day in 17 years after support from Trump’s solicitor general Bayer shares rose as much as 15% on Tuesday after the U.S. solicitor general backed the company’s bid to get the Supreme Court to curtail litigation alleging its Roundup pesticide causes cancer. (https://www.marketwatch.com/) Tue. Dec 2, 2025 | |
| 7 (-3) Bankrupt Genesis Health picks insider bid for its nursing homes Dec 1 (Reuters) - Genesis HealthCare said on Monday that an insider bid had won a bankruptcy auction for all of its assets, which would allow the same ownership group to maintain control of the company's nursing homes while using bankruptcy to slash debts and medical malpractice claims. The winning bid was submitted by CPE 88988 LLC, an affiliate of Genesis' private equity owner, Pima Capital Partners, according to court documents filed in bankruptcy court in Dallas. (https://finance.yahoo.com/) Tue. Dec 2, 2025 | |
| 8 (-5) Vaccine stocks slide as FDA official links COVID vaccines and heart conditions in young men Memo also reportedly mentions vaccines for flu and pneumonia. (https://www.marketwatch.com/) Mon. Dec 1, 2025 | |
| 9 (8) 5 Healthcare Names to Watch as Sector Rotation Is in Full Swing The healthcare sector is outperforming the broader market and tech sector in Q4, confirming a substantial capital shift into the defensive industry. (https://www.marketbeat.com/) Mon. Dec 1, 2025 | |
| 10 (-5) FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become stricter. (https://www.investopedia.com/) Mon. Dec 1, 2025 | |
| 11 (5) Eli Lilly Trims Price of Popular Weight-Loss Drug on Its Site a Month After Trump Deal Eli Lilly said Monday that it's reducing the price of its popular weight-loss drug Zepbound on its LillyDirect platform, about a month after striking a deal with the Trump administration to lower drug costs. (https://www.investopedia.com/) Mon. Dec 1, 2025 | |
| 12 (5) Healthcare & AI on agenda for Congress this month Congress is kicking off its final session of 2025. It's expected that lawmakers will vote on an extension of healthcare subsidies. A couple of pieces of AI legislation may be considered, too. Yahoo Finance Washington Correspondent Ben Werschkul breaks down what's on Congress's agenda for the rest of the year. He shares the details of a tariff deal on pharmaceuticals reached by the US and UK. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime. (https://finance.yahoo.com/) Mon. Dec 1, 2025 | |
| 13 (3) Evercore Hires JPMorgan Health-Care Banking Head Ben Carpenter JPMorgan Chase & Co.’s global co-head of health-care investment banking Ben Carpenter has left the firm for a role at Evercore Inc., according to people familiar with the matter. (https://www.bloomberg.com/) Mon. Dec 1, 2025 | |
| 14 (0) What Eli Lilly's move to cut prices on obesity drug Zepbound means for investors Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading. (https://www.cnbc.com/) Mon. Dec 1, 2025 | |
| 15 (-6) Vaccine stocks slide as FDA official links COVID vaccines and heart conditions in young men Memo also reportedly mentions vaccines for flu and pneumonia. (https://www.marketwatch.com/) Mon. Dec 1, 2025 | |
| 16 (-6) Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men Memo also reportedly mentions vaccines for flu and pneumonia. (https://www.marketwatch.com/) Mon. Dec 1, 2025 | |
| 17 (-6) Higher health-care costs force financial trade-offs: Investors 'worry about all these moving pieces,' top advisor says Rising health insurance premiums and expenses on top of already higher costs for everyday items are forcing people to make trade-offs in their budgets. (https://www.cnbc.com/) Mon. Dec 1, 2025 | |
| 18 (-6) Moderna Falls After FDA Vows to Impose New Vaccine Requirements Moderna Inc. fell in premarket trading Monday after the Food and Drug Administration said in a memo late last week it would place new restrictions on which vaccines hit the market. (https://www.bloomberg.com/) Mon. Dec 1, 2025 | |
| 19 (6) Lilly Cuts Low-Dose Zepbound Price Up to 20% for Cash-Pay Buyers Eli Lilly & Co. is cutting the price for introductory doses of its weight-loss drug Zepbound again, as competition heats up with rival Novo Nordisk A/S. (https://www.bloomberg.com/) Mon. Dec 1, 2025 | |
| 20 (7) Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site The announcement comes weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to access. (https://www.cnbc.com/) Mon. Dec 1, 2025 | |
| 21 (5) Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields (https://www.benzinga.com/) Mon. Dec 1, 2025 | |
| 22 (8) Eli Lilly cuts Zepbound price to widen access for obesity drug Dec 1 (Reuters) - Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S. patients, as demand for (https://finance.yahoo.com/) Mon. Dec 1, 2025 | |
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA